The treatment with perifosine and edelfosine inhibits AKT and induces apoptosis in MCL cells and in xenograft-derived animal models; in the latter, pretreatment with PI3K inhibitor wortmannin potentiates the effect of perifosine [170]. The gene discussed is AKT1; the disease is mantle cell lymphoma.